Filing Flows › Comparisons › PMHS vs ACRS
Polomar Health Services vs Aclaris Therapeutics: PMHS and ACRS compared
Polomar Health Services is the larger company: $1.5M of revenue in its latest quarter (Q2 2026) against $1.5M for Aclaris Therapeutics (Q3 2026). Polomar Health Services is growing faster (279× against -55% a year earlier).
Where the money goes: PMHS and ACRS
Polomar Health Services (PMHS) · Q2 2026
Polomar Health Services, Q2 2026: revenue $1.5M (279× year over year), operating margin 14.3%, net earnings $200K, operating cash flow $121K. The chart follows the revenue to costs, profit and cash.
Aclaris Therapeutics (ACRS) · Q3 2026
Aclaris Therapeutics, Q3 2026: revenue $1.5M (-55% year over year), net loss $18.5M, operating cash flow −$24.1M. The chart follows the revenue to costs, profit and cash.
| Polomar Health Services (PMHS) | Aclaris Therapeutics (ACRS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $1.5M | $1.5M |
| Revenue growth, Y/Y | 279× | -55% |
| Gross margin | 61.2% | — |
| Operating margin | 14.3% | n/m |
| Net earnings | $200K | −$18.5M |
| Net margin | 13.1% | — |
| Operating cash flow | $121K | −$24.1M |
Where the revenue comes from
Aclaris Therapeutics
- Licensing: $1.2M (80%)
- Contract research: $300K (20%)
Questions
Which is bigger, Polomar Health Services or Aclaris Therapeutics?
Polomar Health Services is the larger company: $1.5M of revenue in its latest quarter (Q2 2026) against $1.5M for Aclaris Therapeutics (Q3 2026).
Is Polomar Health Services or Aclaris Therapeutics growing faster?
Polomar Health Services is growing faster (279× against -55% a year earlier).
More: Polomar Health Services earnings · how Polomar Health Services makes money · Aclaris Therapeutics earnings · how Aclaris Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.